Biogen earnings release
WebFeb 15, 2024 · Biogen Inc. (BIIB) delivered earnings and revenue surprises of 15.38% and 4.13%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? WebBiogen (BIIB) will release its next earnings report on Apr 26, 2024. In the last quarter Biogen reported $3.489 EPS in relation to $4.05 expected by the market. ... BIIB Earnings-Related Price Changes. Report Date. Price 1 Day Before. Price 1 Day After. Percentage Change. Feb 15, 2024: $289.08: $278.98-3.49%: Oct 25, 2024: $274.62:
Biogen earnings release
Did you know?
WebOct 20, 2024 · The company’s total shares saw a decline of 21% over this period, and on a per share basis, earnings grew a solid 15% to $24.86 in 2024, as compared to $21.63 in 2024. ... Biogen Press Release ... WebApr 12, 2024 · CAMBRIDGE, Mass. and SOUTH SAN FRANCISCO, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. BIIB and Denali Therapeutics Inc. DNLI today announced that Biogen has exercised the option to ...
WebMar 30, 2024 · CAMBRIDGE, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (NASDAQ: BIIB) today announced the appointment of Chuck Triano as Senior Vice President, Head of Investor Relations effective 10 … WebJul 20, 2024 · Biogen Reports Second Quarter 2024 Results. Second quarter revenue $2,589 million; GAAP diluted EPS $7.24; Non-GAAP diluted EPS $5.25. FDA granted Priority Review for lecanemab in early Alzheimer's disease under the accelerated approval pathway with a decision expected by January 6, 2024; Phase 3 data expected in the Fall …
WebOct 25, 2024 · Biogen Inc. (BIIB) came out with quarterly earnings of $4.77 per share, beating the Zacks Consensus Estimate of $4.13 per share. This compares to earnings of $4.77 per share a year ago. WebFeb 15, 2024 · Ahead of this earnings release, the estimate revisions trend for Biogen Inc. Mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock.
WebBiogen (BIIB) will release its next earnings report on Apr 26, 2024. In the last quarter Biogen reported $3.489 EPS in relation to $4.05 expected by the market. ... BIIB …
WebFeb 15, 2024 · SOD1-ALS is a rare genetic form of the disease affecting approximately 330 people in the United States CAMBRIDGE, Mass., March 22, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced today the outcome of the U.S. Food and Drug … how far is pa from txhow far is pagosa springs from denver airporthttp://newsroom.biogen.com/news/news-releases high brow greenslopesWebApr 12, 2024 · CAMBRIDGE, Mass. and SOUTH SAN FRANCISCO, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that Biogen has exercised the option to license Denali’s Antibody Transport Vehicle (ATV):Amyloid beta program (ATV:Aß). Accumulation of Aß plaque in … highbrow healthcareWebFeb 15, 2024 · Biogen Inc. (BIIB) came out with quarterly earnings of $4.05 per share, beating the Zacks Consensus Estimate of $3.51 per share. This compares to earnings of $3.39 per share a year ago. highbrow film maker crosswordWebFeb 15, 2024 · Biogen Inc. (BIIB) came out with quarterly earnings of $4.05 per share, beating the Zacks Consensus Estimate of $3.51 per share. This compares to earnings … highbrowfurniture.comWebThe new Prescription Drug User Fee Act (PDUFA) action date set by the FDA is April 25, 2024 CAMBRIDGE, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. … high brow glasses